Novel approach improves the efficacy of immune checkpoint blockade and minimizes related side effects

Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade (ICB) - a novel form of cancer treatment utilizing immune checkpoint inhibitors (ICIs) - and minimizes the associated side effects.

Related Keywords

Megan Craig ,Tetsuya Kodama ,Clinical Cancer Research On ,Tohoku University Graduate School Of Biomedical Engineering ,Scientists At Tohoku University ,Tohoku University ,Clinical Cancer Research ,Professor Tetsuya Kodama ,Graduate School ,Biomedical Engineering ,Tumor ,Dancer ,Cancer Treatment ,Efficacy ,Immune System ,Lymph Node ,Lymph Nodes ,Pneumonia ,Research ,